G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/50 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2405900
Methods and kits for determining whether an individual is susceptible to developing impaired glucose tolerance (IGT), impaired fasting glucose (IFG), or Type-2 diabetes are described. Such methods include administering GIP or GIP variant and nutrient to an individual, measuring the response of the individual and determining whether the individual is susceptible to developing IGT, Type-2 diabetes, or IFG.
L'invention concerne des méthodes et des kits permettant de déterminer si un individu est susceptible de développer une intolérance au glucose (IGT), une glycémie à jeun (IFG), ou des diabètes de type 2. Ces méthodes consistent à administrer un polypeptide inhibiteur gastrique ou un variant de polypeptide inhibiteur gastrique et une substance nutritive à un individu, mesurer la réponse de l'individu et déterminer si cet individu est susceptible de développer une intolérance au glucose (IGT), des diabètes de type 2 ou une glycémie à jeun (IFG).
Huecking Katrin
Meier Juris J.
Nauck Michael A.
Bionebraska Inc.
Deeth Williams Wall Llp
Restoragen Inc.
LandOfFree
Gastric inhibitory polypeptide diagnostic test for detecting... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gastric inhibitory polypeptide diagnostic test for detecting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gastric inhibitory polypeptide diagnostic test for detecting... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1874304